###begin article-title 0
###xml 114 118 <span type="species:ncbi:10090">mice</span>
SirT1 modulates the estrogen-insulin-like growth factor-1 signaling for postnatal development of mammary gland in mice
###end article-title 0
###begin p 1
This is an open access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Introduction
###end title 2
###begin p 3
###xml 521 525 <span type="species:ncbi:10090">mice</span>
Estrogen and insulin-like growth factor-1 (IGF-1) play important roles in mammary gland development and breast cancer. SirT1 is a highly conserved protein deacetylase that can regulate the insulin/IGF-1 signaling in lower organisms, as well as a growing number of transcription factors, including NF-kappaB, in mammalian cells. Whether SirT1 regulates the IGF-1 signaling for mammary gland development and function, however, is not clear. In the present study, this role of SirT1 was examined by studying SirT1-deficient mice.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 22 27 22 27 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko</sup>
###xml 148 153 148 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink">co/co</sup>
###xml 29 33 <span type="species:ncbi:10090">mice</span>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
###xml 160 163 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 168 183 <span type="species:ncbi:10090">transgenic mice</span>
###xml 368 372 <span type="species:ncbi:10090">mice</span>
SirT1-deficient (SirT1ko/ko) mice were generated by crossing a new strain of mice harboring a conditional targeted mutation in the SirT1 gene (SirT1co/co) with CMV-Cre transgenic mice. Whole mount and histology analyses, immunofluorescence staining, immunohistochemistry, and western blotting were used to characterize mammary gland development in virgin and pregnant mice. The effect of exogenous estrogen was also examined by subcutaneous implantation of a slow-releasing pellet in the subscapular region.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 26 32 26 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 106 112 106 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 179 185 179 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 437 443 437 443 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 717 723 697 703 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 32 36 <span type="species:ncbi:10090">mice</span>
###xml 112 116 <span type="species:ncbi:10090">mice</span>
###xml 185 189 <span type="species:ncbi:10090">mice</span>
Both male and female SirT1ko/ko mice can be fertile despite the growth retardation phenotype. Virgin SirT1ko/ko mice displayed impeded ductal morphogenesis, whereas pregnant SirT1ko/ko mice manifested lactation failure due to an underdeveloped lobuloalveolar network. Estrogen implantation was sufficient to rescue ductal morphogenesis. Exogenous estrogen reversed the increased basal level of IGF-1 binding protein-1 expression in SirT1ko/ko mammary tissues, but not that of IkappaBalpha expression, suggesting that increased levels of estrogen enhanced the production of local IGF-1 and rescued ductal morphogenesis. Additionally, TNFalpha treatment enhanced the level of the newly synthesized IkappaBalpha in SirT1ko/ko cells. SirT1 deficiency therefore affects the cellular response to multiple extrinsic signals.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 105 109 <span type="species:ncbi:10090">mice</span>
SirT1 modulates the IGF-1 signaling critical for both growth regulation and mammary gland development in mice. SirT1 deficiency deregulates the expression of IGF-1 binding protein-1 and attenuates the effect of IGF-1 signals, including estrogen-stimulated local IGF-1 signaling for the onset of ductal morphogenesis. These findings suggest that the enzymatic activity of SirT1 may influence both normal growth and malignant growth of mammary epithelial cells.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 105 106 105 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 107 108 107 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 370 371 370 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 372 373 372 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 525 526 525 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 527 528 527 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 727 728 727 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 144 149 <span type="species:ncbi:4932">yeast</span>
###xml 221 226 <span type="species:ncbi:4932">Yeast</span>
###xml 426 431 <span type="species:ncbi:4932">yeast</span>
###xml 629 634 <span type="species:ncbi:4932">yeast</span>
Mammalian SirT1 belongs to a family of nicotinamide adenine dinucleotide-dependent histone deacetylases [1,2]. SirT1 is most closely related to yeast Sir2, the founding member of the evolutionarily conserved Sir2 family. Yeast Sir2 is required for silencing transcription at the telomeric region and mating type loci, and for suppression of ribosomal DNA recombination [3,4]. The expression of an extra copy of Sir2 in either yeast mother cells or multicell organisms such as nematodes can significantly extend the lifespan [5,6]. Inactivation of Sir2 enhances stress resistance and extends chronological lifespan of nondividing yeast cells, which is opposite to the requirement for Sir2 function in the reproductive lifespan [7]. Whether SirT1 regulates the reproductive lifespan and/or the chronological lifespan in mammals remains unknown.
###end p 11
###begin p 12
###xml 134 156 134 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Caenorhabditis elegans</italic>
###xml 172 182 172 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 203 204 203 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 205 206 205 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 717 719 717 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 720 722 720 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 904 906 904 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1147 1158 1147 1158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. elegans </italic>
###xml 1159 1160 1159 1160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1161 1162 1161 1162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1163 1165 1163 1165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1247 1249 1247 1249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1416 1418 1416 1418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1419 1421 1419 1421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 134 156 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
###xml 159 170 <span type="species:ncbi:7227">fruit flies</span>
###xml 185 189 <span type="species:ncbi:10090">mice</span>
###xml 195 201 <span type="species:ncbi:9606">humans</span>
###xml 1147 1157 <span type="species:ncbi:6239">C. elegans</span>
###xml 1255 1259 <span type="species:ncbi:10090">mice</span>
###xml 1264 1270 <span type="species:ncbi:9606">humans</span>
Sir2 is an integral part of an evolutionarily conserved insulin/insulin-like growth factor-1 (IGF-1) signaling (IIS) system in worms (Caenorhabditis elegans), fruit flies (Drosophila), mice, and humans [8,9]. The IIS system includes membrane-bound receptors, cytoplasmic kinases, and nuclear transcription factors. To maintain the proper expression of the effector genes for the IIS system, these conserved components form a sophisticated regulatory system, which centers on a family of forkhead transcription factors (forkhead box 'other' proteins (FoxOs)), and operates on two levels. On one level, SirT1-mediated protein deacetylation attenuates the transcriptional activity of nuclear FoxO transcription factors [10-12]. On the second level, the FoxO transcription factors can be sequestered within the cytoplasm when phosphorylated by activated Akt kinases in response to insulin and IGF-1 signals [13]. Conceivably, the IIS system senses the levels of insulin and IGF-1 and negatively regulates the expression of the effector genes. The IIS system is responsible for food storage, stress tolerance, and longevity in lower organisms, such as C. elegans [8,9,14]. In more advanced species, steroid hormones evolved to regulate the IIS system [15]. In mice and humans, the IGF-1 signaling of the IIS system mediates local effects for growth and hormonal regulation for multiple tissues, including mammary glands [16,17].
###end p 12
###begin p 13
###xml 249 251 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 252 254 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 435 437 427 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 438 440 430 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 567 572 559 564 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko</sup>
###xml 620 626 612 618 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 742 744 734 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 273 277 <span type="species:ncbi:10090">mice</span>
###xml 574 578 <span type="species:ncbi:10090">mice</span>
###xml 626 630 <span type="species:ncbi:10090">mice</span>
###xml 736 740 <span type="species:ncbi:10090">mice</span>
Mammalian SirT1 has evolved to modify the activity of a growing number of transcription factors, including p53, NF-kappaB, and PGC-1alpha, suggesting that SirT1 functions in a wide range of cellular responses to stress, inflammation, and nutrients [18-21]. SirT1-deficient mice display characteristic phenotypes of perinatal death and growth retardation as well as other diverse phenotypes, such as eye defects, with varying severity [22,23]. The underlying causal mechanism for these phenotypes, however, remains unknown. We recently generated SirT1-deficient (SirT1ko/ko) mice and found that both male and female SirT1ko/ko mice can be fertile, which is in contrast to the sterile phenotypes observed in one strain of SirT1-deficient mice [22]. This led to our study of the link between SirT1 and IGF-1 signaling using the mammary gland as a model organ.
###end p 13
###begin p 14
###xml 377 379 377 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 380 382 380 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 383 385 383 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 623 625 623 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 760 762 756 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 763 765 759 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 766 768 762 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 1049 1051 1045 1047 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1052 1054 1048 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1055 1057 1051 1053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 628 632 <span type="species:ncbi:10090">Mice</span>
The mammary gland is a unique organ because it develops after birth and undergoes dynamic changes throughout the reproductive lifespan of a female. At the onset of puberty, ovarian estrogen stimulates ductal morphogenesis during which mammary epithelial progenitor cells differentiate and proliferate while interacting with adipocytes and stromal cells within mammary fat pad [17,24,25]. Ovarian estrogen, in synergy with pituitary growth hormone (GH), stimulates stromal cells to produce local IGF-1. The local IGF-1, but not liver-produced systemic IGF-1, provides a paracrine signal for commencing ductal morphogenesis [26]. Mice lacking GH, estrogen, IGF-1, GH receptor, or estrogen receptor alpha (ERalpha) fail to undergo postnatal ductal morphogenesis [17,24-31], indicating that both steroid hormones and IGF-1 are on the common pathway for a critical developmental checkpoint. Once the arborated ductal network is established, cycles of differentiation, proliferation, and death of secretory alveolar epithelium repeat with each pregnancy [17,24,25].
###end p 14
###begin p 15
###xml 113 119 113 119 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 154 160 154 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 119 123 <span type="species:ncbi:10090">mice</span>
In the present article we report the finding and characterization of impeded ductal morphogenesis in virgin SirT1ko/ko mice and lactation failure in SirT1ko/ko mothers. The characterization of these phenotypes has identified a SirT1-dependent regulatory mechanism by which SirT1 modulates the effectiveness of the estrogen-IGF-1 signaling for mammary gland development. The estrogen-IGF-1 signaling is defined as the ovarian estrogen-regulated, stromal cell-produced local IGF-1 signal for stimulating mammary epithelial cells.
###end p 15
###begin title 16
Materials and methods
###end title 16
###begin title 17
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 17
###begin p 18
###xml 56 58 56 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 153 159 153 159 <sup xmlns:xlink="http://www.w3.org/1999/xlink">co/co </sup>
###xml 211 217 211 217 <sup xmlns:xlink="http://www.w3.org/1999/xlink">co/co </sup>
###xml 342 347 342 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/ko </sup>
###xml 364 370 364 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink">co/co </sup>
###xml 384 389 384 389 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/co </sup>
###xml 455 461 455 461 <sup xmlns:xlink="http://www.w3.org/1999/xlink">co/co </sup>
###xml 470 476 470 476 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 506 512 506 512 <sup xmlns:xlink="http://www.w3.org/1999/xlink">co/co </sup>
###xml 526 532 526 532 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 82 86 <span type="species:ncbi:10090">mice</span>
###xml 159 163 <span type="species:ncbi:10090">mice</span>
###xml 217 221 <span type="species:ncbi:10090">mice</span>
###xml 226 229 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 234 249 <span type="species:ncbi:10090">transgenic mice</span>
###xml 261 265 <span type="species:ncbi:10090">mice</span>
###xml 347 351 <span type="species:ncbi:10090">mice</span>
###xml 370 374 <span type="species:ncbi:10090">mice</span>
###xml 389 393 <span type="species:ncbi:10090">mice</span>
###xml 476 480 <span type="species:ncbi:10090">mice</span>
###xml 512 516 <span type="species:ncbi:10090">mice</span>
###xml 532 536 <span type="species:ncbi:10090">mice</span>
###xml 578 582 <span type="species:ncbi:10090">Mice</span>
###xml 970 976 <span type="species:ncbi:10090">Murine</span>
A previously described SirT1 targeting construct, KOII [23], was used to generate mice harboring a conditional targeted mutation in the SirT1 gene (SirT1co/co mice) (see Additional file 1). The breeding of SirT1co/co mice and CMV-Cre transgenic mice results in mice harboring a germline-transmitted deletion of exon 4 of the SirT1 gene (SirT1+/ko mice). Both SirT1co/co mice and SirT1+/co mice were used to establish breeding colonies for generating SirT1co/co and SirT1ko/ko mice, respectively. Both SirT1co/co mice and SirT1ko/ko mice were in a mixed 129SvJ/C57B6 background. Mice were housed in a special-pathogen-free facility and all procedures were approved by the University of Washington Animal Care and Use Committee. A PCR-based genotyping method was established to identify the wild-type, co, and ko loci of the SirT1 gene using three primers: 5' co primer, 5'-GGTTGACTTAGGTCTTGTCTG; 5' ko primer, 5'-AGGCGGATTTCTGAGTTCGA; 3' primer, 5'-CGTCCCTTGTAATGTTTCCC. Murine embryonic fibroblasts (MEFs) were isolated from the embryos between embryonic day 12.5 and embryonic day 14.5. The body weight was measured once a week.
###end p 18
###begin title 19
Serum insulin-like growth factor-1
###end title 19
###begin p 20
A commercial radioimmunoassay (ALPCO Inc., Windham, NH, USA) was used. Samples (300 mul) were prepared via an alcohol extraction followed by a 2-day disequilibrium incubation at 4degreesC. Samples were measured in duplicate and data were calculated as the samples were counted. Six standards ranging from 10 to 500 ng/ml were used to generate the standard curve. The lower limit of detection was 10 ng.
###end p 20
###begin title 21
Survival assay
###end title 21
###begin p 22
###xml 216 219 216 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink">137</sup>
To determine the sensitivity of embryonic stem cells after ionizing radiation or hydrogen peroxide treatment, 300 embryonic stem cells were seeded onto a 10-cm plate for 24 hours. The plates were either exposed to a 137Cs source at indicated doses or were treated with embryonic stem media containing hydrogen peroxide at indicated concentrations for 30 minutes. Seven days after irradiation or hydrogen peroxide treatment, the embryonic stem colonies stained with crystal violet were counted.
###end p 22
###begin title 23
Estrogen implantation
###end title 23
###begin p 24
###xml 236 240 <span type="species:ncbi:10090">mice</span>
Estrogen pellets in the form of 17beta-estradiol, at 0.1 mg, and the 21-day releasing time were obtained from Innovative Research (Sarasota, FL, USA). One pelletwas subcutaneously implanted in the subscapular region ofindividual female mice using a sterilizedmetal trochar (Innovative Research).
###end p 24
###begin title 25
Whole mount analysis
###end title 25
###begin p 26
The inguinoabdominal mammary fat pads were spread on microscope slides, fixed in Carnoy's fixative overnight, hydrated and stained with carmine alum stain (Sigma, St. Louis, MO, USA) overnight, and were then dehydrated, treated with xylene to remove fat, and mounted with Secure Mount (Fisher Scientific, Pittsburgh, PA, USA) and cover slips.
###end p 26
###begin title 27
Histological, immunohistochemical, and immunofluorescence analyses
###end title 27
###begin p 28
###xml 4 8 <span type="species:ncbi:10090">mice</span>
###xml 525 530 <span type="species:ncbi:10090">mouse</span>
###xml 548 554 <span type="species:ncbi:9986">rabbit</span>
###xml 560 565 <span type="species:ncbi:10090">mouse</span>
###xml 712 718 <span type="species:ncbi:9986">rabbit</span>
The mice were given a single dose of bromodeoxyurdine (BrdU) at 100 g/kg body weight via intraperitoneal injection 2 hours before euthanasia. The mammary fat pads, as well as other tissues, were collected and fixed in 10% formalin solution (Fisher Scientific). Paraffin-embedded sections were prepared at 4 mum thickness followed by standard H & E staining for histological analysis and by immunohistochemical staining for BrdU-labeled cells (Sigma) and apoptotic cells (Promega, Madison, WI, USA). To detect the presence of mouse milk proteins, a rabbit anti-mouse milk specific protein antibody (Nordic Immunology, Tillburg, The Netherlands) was used for immunofluorescent staining, followed by Texas Red anti-rabbit secondary antibody (Molecular Probes) and DAPI staining for nuclei (Molecular Probe, Eugene, OR, USA). Microscopic analyses of all histological findings were carried out on an AxioVert 200M microscope with AxioVision 4.5 software (Carl Zeiss, Munchen-Hallbergmoos, Germany).
###end p 28
###begin title 29
Protein analysis
###end title 29
###begin p 30
###xml 381 392 <span type="species:ncbi:3704">horseradish</span>
###xml 420 426 <span type="species:ncbi:9986">rabbit</span>
###xml 461 464 <span type="species:ncbi:10116">rat</span>
###xml 475 479 <span type="species:ncbi:9925">goat</span>
Protein extracts were prepared from mammary tissues as well as from MEFs. The following primary antibodies were used: anti-SirT1 (Upstate Biotechology, Lake Placid, NY, USA), anti-IGF-1 binding protein-1 (IGFBP-1) (R&D Systems, Minneapolis, MN, USA), and anti-actin and anti-IkappaBalpha (Santa Cruz Biotechnology, Santa Cruz, CA, USA). The corresponding secondary antibodies were horseradish peroxidase-conjugated anti-rabbit (Pierce, Rockford, IL, USA), anti-rat, and anti-goat (Santa Cruz Biotechnology).
###end p 30
###begin title 31
Results
###end title 31
###begin title 32
###xml 27 33 27 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 33 37 <span type="species:ncbi:10090">mice</span>
Growth retardation in SirT1ko/ko mice
###end title 32
###begin p 33
###xml 49 55 49 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink">co/co </sup>
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1a</xref>
###xml 282 288 282 288 <sup xmlns:xlink="http://www.w3.org/1999/xlink">co/co </sup>
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1b</xref>
###xml 324 330 324 330 <sup xmlns:xlink="http://www.w3.org/1999/xlink">co/co </sup>
###xml 455 461 455 461 <sup xmlns:xlink="http://www.w3.org/1999/xlink">co/co </sup>
###xml 558 562 558 562 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/ko</sup>
###xml 571 573 571 573 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 712 714 712 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1a</xref>
###xml 805 807 801 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 815 819 811 815 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/ko</sup>
###xml 824 826 820 822 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 955 960 951 956 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/ko </sup>
###xml 988 993 984 989 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/ko </sup>
###xml 1012 1017 1008 1013 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/ko </sup>
###xml 1046 1052 1042 1048 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 1093 1098 1089 1094 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/ko </sup>
###xml 1111 1117 1107 1113 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 1201 1203 1197 1199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1b</xref>
###xml 1275 1280 1271 1276 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/ko </sup>
###xml 1356 1369 1348 1357 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ex4/&#916;ex4 </sup>
###xml 1424 1426 1412 1414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 38 42 <span type="species:ncbi:10090">mice</span>
###xml 55 59 <span type="species:ncbi:10090">mice</span>
###xml 288 292 <span type="species:ncbi:10090">mice</span>
###xml 330 334 <span type="species:ncbi:10090">mice</span>
###xml 387 391 <span type="species:ncbi:10090">mice</span>
###xml 461 465 <span type="species:ncbi:10090">mice</span>
###xml 484 487 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 492 507 <span type="species:ncbi:10090">transgenic mice</span>
###xml 564 567 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 605 608 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 826 830 <span type="species:ncbi:10090">mice</span>
###xml 863 867 <span type="species:ncbi:10090">mice</span>
###xml 884 888 <span type="species:ncbi:10090">mice</span>
###xml 960 964 <span type="species:ncbi:10090">mice</span>
###xml 998 1002 <span type="species:ncbi:10090">mice</span>
###xml 1024 1028 <span type="species:ncbi:10090">mice</span>
###xml 1052 1056 <span type="species:ncbi:10090">mice</span>
###xml 1098 1102 <span type="species:ncbi:10090">mice</span>
###xml 1117 1121 <span type="species:ncbi:10090">mice</span>
###xml 1280 1284 <span type="species:ncbi:10090">mice</span>
###xml 1337 1341 <span type="species:ncbi:10090">mice</span>
###xml 1369 1373 <span type="species:ncbi:10090">mice</span>
###xml 1418 1422 <span type="species:ncbi:10090">mice</span>
The conditional targeted SirT1 mutant mice (SirT1co/co mice) carry an insertion mutation of the neomycin-resistant gene and lox sequences in the SirT1 gene flanking exon 4 that encodes a conserved Sir2 motif (Figure 1a). The mutation does not affect the expression of SirT1 in SirT1co/co mice (Figure 1b). As expected, SirT1co/co mice are phenotypically indistinguishable from wild-type mice. To convert the SirT1 co allele into the SirT1 ko allele, SirT1co/co mice were crossed with CMV-Cre transgenic mice to generate SirT1 heterozygotes carrying the SirT1+/ko, CMV-Cre+ genotype. The expression of the CMV-Cre transgene catalyzes the deletion of exon 4 in most lineages of cells, including germ cells (Figure 1a). This SirT1 ko allele should be identical to the previously described Deltaex4 mutation [23]. SirT1+/ko, Cre+ mice were backcrossed with wild-type mice to generate the mice harboring a germline-transmitted deletion mutation (that is, SirT1+/ko mice). The breeding of SirT1+/ko male mice and SirT1+/ko female mice resulted in SirT1ko/ko mice. The cells derived from either SirT1+/ko mice or SirT1ko/ko mice expressed a SirT1 mutant protein due to the inframe deletion of exon 4 (Figure 1b). This SirT1 mutant protein may not be functional, however, since SirT1+/ko mice are phenotypically indistinguishable from wild-type mice and SirT1Deltaex4/Deltaex4 mice were phenotypically identical to SirT1 null mice [23].
###end p 33
###begin p 34
###xml 76 82 76 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 150 156 150 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 196 197 196 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 209 211 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1c</xref>
###xml 214 216 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 217 219 217 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 378 384 378 384 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 432 434 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1d</xref>
###xml 522 528 522 528 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 791 793 791 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 794 796 794 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 818 824 818 824 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 1060 1064 1060 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1e,f</xref>
###xml 1154 1156 1154 1156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 1157 1159 1157 1159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 1203 1209 1203 1209 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 44 48 <span type="species:ncbi:10090">mice</span>
###xml 156 160 <span type="species:ncbi:10090">mice</span>
###xml 384 388 <span type="species:ncbi:10090">mice</span>
###xml 528 532 <span type="species:ncbi:10090">mice</span>
###xml 619 624 <span type="species:ncbi:4932">yeast</span>
###xml 673 678 <span type="species:ncbi:10090">mouse</span>
###xml 1087 1091 <span type="species:ncbi:10090">mice</span>
###xml 1110 1114 <span type="species:ncbi:10090">mice</span>
###xml 1209 1213 <span type="species:ncbi:10090">mice</span>
Similar to other strains of SirT1-deficient mice, nearly two-thirds of SirT1ko/ko newborns die shortly after birth and the majority of surviving SirT1ko/ko mice manifest growth retardation (Table 1 and Figure 1c) [22,23]. Growth retardation may result from a systemic defect in hormonal regulation, DNA double-strand break repair, or other causal mechanisms. We found that SirT1ko/ko mice have reduced levels of serum IGF-1 (Figure 1d). IGF-1 often acts as a local effector for pituitary GH. The serum level of GH in SirT1ko/ko mice, however, appeared to be within the normal range (data not shown). On the other hand, yeast Sir2 and its associated Sir complex, as well as mouse SirT6, have also been implicated in DNA double-strand break repair and the maintenance of chromosome stability [32-34]. We found that SirT1ko/ko embryonic stem cells do not have increased sensitivity to either ionizing radiation or hydrogen peroxide treatment when compared with wild-type cells, or with positive control cells such as Ku70-deficient or Atm-deficient cells (Figure 1e,f). Both Ku70-deficient mice and Atm-deficient mice display growth retardation phenotypes [35,36]. The growth retardation phenotype in SirT1ko/ko mice is therefore probably not due to a defect in DNA damage repair, but rather results from a deficit in IGF-1 signaling.
###end p 34
###begin title 35
Lactation failure
###end title 35
###begin p 36
###xml 26 32 26 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 169 175 169 175 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 204 209 204 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/ko </sup>
###xml 244 250 244 250 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 325 326 325 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 365 370 365 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/ko </sup>
###xml 407 413 407 413 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 425 426 425 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 453 459 453 459 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 32 36 <span type="species:ncbi:10090">mice</span>
###xml 143 147 <span type="species:ncbi:10090">mice</span>
###xml 175 179 <span type="species:ncbi:10090">mice</span>
###xml 209 213 <span type="species:ncbi:10090">mice</span>
###xml 370 374 <span type="species:ncbi:10090">mice</span>
###xml 413 417 <span type="species:ncbi:10090">mice</span>
Both male and female SirT1ko/ko mice can be fertile, which is in contrast with the reported sterile phenotype in one strain of SirT1-deficient mice [22]. When male SirT1ko/ko mice impregnated female SirT1+/ko mice, the number of surviving SirT1ko/ko offspring was reduced due to the partial perinatal lethal phenotype (Table 1). In a reciprocal approach, male SirT1+/ko mice can also impregnate female SirT1ko/ko mice (Table 1). After parturition, SirT1ko/ko mothers exhibited normal nursing behavior. The pups did not survive for more than 3 days after birth, however, unless they were immediately removed and put under the care of a foster mother. All pups died of dehydration or starvation as a result of lack of milk in their stomachs.
###end p 36
###begin p 37
###xml 30 36 30 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 215 221 215 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 388 390 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2a</xref>
###xml 456 462 456 462 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 501 503 501 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2b</xref>
###xml 640 646 640 646 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 814 818 814 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2b,c</xref>
###xml 221 225 <span type="species:ncbi:10090">mice</span>
###xml 323 327 <span type="species:ncbi:10090">mice</span>
###xml 462 466 <span type="species:ncbi:10090">mice</span>
###xml 653 657 <span type="species:ncbi:10090">mice</span>
To determine whether the SirT1ko/ko mothers encountered a lactation defect, whole mount and histological analyses were used to characterize the morphological changes in the mammary glands. We found that virgin SirT1ko/ko mice displayed impeded ductal morphogenesis up to 9 months of age, while age-matched virgin wild-type mice displayed extensive ductal elongation and branching (Figure 2a). The absence of ductal morphogenesis persisted in pregnant SirT1ko/ko mice up to day 13 of pregnancy (Figure 2b). Despite the fact that pregnancy can induce ductal morphogenesis at the late stage of pregnancy, underdeveloped mammary glands in SirT1ko/ko female mice cause a severe deficit in milk production, as shown by histological analysis as well as the immunofluorescence analysis using an anti-milk antibody (Figure 2b,c).
###end p 37
###begin title 38
Pregnancy-induced mammary gland development
###end title 38
###begin p 39
###xml 110 116 110 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 225 227 225 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 348 350 348 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 351 353 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 462 464 462 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 551 557 551 557 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 702 704 702 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 735 741 735 741 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 1006 1008 1006 1008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 1112 1118 1112 1118 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
###xml 263 267 <span type="species:ncbi:10090">mice</span>
###xml 447 451 <span type="species:ncbi:10090">mice</span>
###xml 564 568 <span type="species:ncbi:10090">mice</span>
###xml 741 745 <span type="species:ncbi:10090">mice</span>
###xml 1118 1122 <span type="species:ncbi:10090">mice</span>
To characterize the developmental defect leading to lactation failure, we analyzed the mammary glands of SirT1ko/ko female mice on lactation day 1. Terminal end buds (TEBs) are club-shaped transitional structures (see Figure 3a, upper panel). In wild-type female mice, TEBs form and precede ductal elongation and branching at the onset of puberty [17,24,25]. When TEBs/ducts reach the edge of mammary fat pads, TEBs regress as shown in the virgin mice in Figure 3a (upper panel). Interestingly, the transitional TEBs can be readily identified in SirT1ko/ko female mice on lactation day 1, manifesting as either newly formed TEBs or as TEBs attached to developing ductal and alveolar structures (Figure 3a, lower panel). Moreover, SirT1ko/ko mice displayed varying degrees of ductal development, ranging from a lack of any ductal structure to a fully developed ductal network, the latter of which is comparable with the morphology and cellularity of wild-type mammary tissues on day 13 of pregnancy (Figure 3a). These observations indicated that pregnancy could rescue impeded ductal morphogenesis in virgin SirT1ko/ko mice.
###end p 39
###begin p 40
###xml 134 136 134 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 137 139 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 140 142 140 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 325 327 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2b</xref>
###xml 332 334 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 350 356 350 356 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 582 584 582 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2c</xref>
###xml 589 591 589 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 652 658 652 658 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 788 790 788 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2c</xref>
###xml 290 294 <span type="species:ncbi:10090">mice</span>
###xml 356 360 <span type="species:ncbi:10090">mice</span>
###xml 658 662 <span type="species:ncbi:10090">mice</span>
###xml 775 779 <span type="species:ncbi:10090">mice</span>
Normal alveolar morphogenesis takes place under the control of additional hormones and growth factors during pregnancy and lactation [17,24,25]. These coordinated efforts are necessary to support a densely saturated lobuloalveolar system for secreting milk after parturition (see wild-type mice on lactation day 1 in Figures 2b and 3a). In some SirT1ko/ko mice, the alveolar morphogenesis was initiated, as indicated by the presence of a few secretory alveolar epithelial cells within scattered alveolar structures sprouted from a well-established ductal branching network (Figures 2c and 3a, lower panel). The extent of alveolar morphogenesis in SirT1ko/ko mice was inadequate, however, as shown by the severe deficit in milk production when compared with that in wild-type mice (Figure 2c).
###end p 40
###begin title 41
Exogenous estrogen-induced ductal morphogenesis
###end title 41
###begin p 42
###xml 121 127 121 127 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 218 224 218 224 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 437 439 437 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4a</xref>
###xml 472 478 472 478 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 678 684 678 684 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 777 783 777 783 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 803 805 803 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4a</xref>
###xml 948 954 948 954 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 1438 1444 1438 1444 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 61 65 <span type="species:ncbi:10090">mice</span>
###xml 127 131 <span type="species:ncbi:10090">mice</span>
###xml 224 229 <span type="species:ncbi:10090">mouse</span>
###xml 328 332 <span type="species:ncbi:10090">mice</span>
###xml 478 482 <span type="species:ncbi:10090">mice</span>
###xml 602 606 <span type="species:ncbi:10090">mice</span>
###xml 684 688 <span type="species:ncbi:10090">mice</span>
###xml 790 794 <span type="species:ncbi:10090">mice</span>
###xml 954 958 <span type="species:ncbi:10090">mice</span>
###xml 1444 1448 <span type="species:ncbi:10090">mice</span>
To test whether the increased levels of estrogen in pregnant mice were sufficient to induce ductal morphogenesis in SirT1ko/ko mice, a single estrogen pellet was implanted in the subscapular region of each virgin SirT1ko/ko mouse and the mammary tissues were analyzed 14 and 21 days after the implantation. By day 14, wild-type mice displayed ductal side branching reminiscent of the morphological changes during early pregnancy (Figure 4a, left panel). In contrast, SirT1ko/ko mice showed TEBs and ductal elongation, which are the characteristic features of ductal morphogenesis in pubertal wild-type mice. By day 21, ductal elongation and side branching were restored in SirT1ko/ko mice and the extent of ductal morphogenesis was indistinguishable between wild-type and SirT1ko/ko female mice (Figure 4a, right panel). These observations clearly indicated that exogenous estrogen alone is sufficient to rescue ductal morphogenesis in virgin SirT1ko/ko mice. Furthermore, the presence of transitional TEBs on day 14 and of ductal side branching on day 21 suggested that the characteristic features of mammary gland development at puberty and during early pregnancy could be coupled in response to increasing levels of estrogen. Increased levels of estrogen, either during pregnancy or through implantation, were therefore sufficient to stimulate the differentiation of epithelial progenitor cells and ductal morphogenesis in virgin SirT1ko/ko mice.
###end p 42
###begin title 43
Concurrent mammary epithelial cell proliferation and differentiation
###end title 43
###begin p 44
###xml 143 149 143 149 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 408 414 408 414 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 614 616 614 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5a</xref>
###xml 631 633 631 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5b</xref>
###xml 875 881 875 881 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 991 993 991 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 1172 1174 1172 1174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2c</xref>
###xml 1424 1430 1424 1430 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 149 153 <span type="species:ncbi:10090">mice</span>
###xml 881 885 <span type="species:ncbi:10090">mice</span>
###xml 1430 1434 <span type="species:ncbi:10090">mice</span>
The finding of pregnancy-induced mammary gland development prompted us to investigate how mammary epithelial progenitor cells in pregnant SirT1ko/ko mice can differentiate so rapidly. Both BrdU labeling and the TUNEL (Terminal deoxynucleotidyl transferase mediated dUTP Nick End Labeling) assay were used to measure the cell proliferation and apoptosis in the mammary tissues, respectively. We found in SirT1ko/ko mammary tissues that about one-third of the cells in TEBs were BrdU-positive as compared with the number of BrdU-positive cells in the newly differentiated ductal or alveolar epithelial cells (Figure 5a(upper panel), 5b). This BrdU-positive finding differs from that in wild-type mammary tissues, in which less than 3% of ductal epithelial cells and about 25% of alveolar epithelial cells were BrdU-positive. The newly generated ductal epithelial cells in SirT1ko/ko mice formed elongated ducts and side branches, while pushing TEBs towards the edge of mammary fat pad (Figure 3a, lower panel). The newly generated ductal epithelial cells can consequently further differentiate into a few observed alveolar cells in which milk proteins were detected (Figure 2c). These observations suggested that the proliferation and differentiation of epithelial progenitor cells, which is programmed to take place at different times of a female's reproductive life, could be concurrent at a late stage of pregnancy in SirT1ko/ko mice.
###end p 44
###begin p 45
###xml 92 94 92 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 95 97 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 98 100 98 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 203 209 203 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 241 243 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5a</xref>
###xml 466 468 466 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5c</xref>
###xml 569 575 569 575 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 799 804 799 804 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/ko </sup>
###xml 817 823 817 823 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 890 896 890 896 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 209 213 <span type="species:ncbi:10090">mice</span>
###xml 339 343 <span type="species:ncbi:10090">mice</span>
###xml 409 413 <span type="species:ncbi:10090">mice</span>
###xml 575 579 <span type="species:ncbi:10090">mice</span>
###xml 692 696 <span type="species:ncbi:10090">mice</span>
###xml 1030 1034 <span type="species:ncbi:10090">mice</span>
###xml 1079 1083 <span type="species:ncbi:10090">mice</span>
Apoptosis is a part of the self-renewal and remodeling processes in normal mammary tissues [17,24,25]. Apoptotic epithelial cells can be readily identified in both ductal and alveolar epithelium of SirT1ko/ko mice on lactation day 1 (Figure 5a, lower panel). The levels of apoptotic cells were significantly higher than those in wild-type mice on lactation day 1, but seemed to be closer to that in wild-type mice in mid-pregnancy (e.g. day 13 of pregnancy) (Figure 5c). The rush of proliferation and differentiation during pregnancy-rescued ductal development in SirT1ko/ko mice manifested multiple features on lactation day 1 that could reassemble some characteristic features of wild-type mice in mid-pregnancy. Successive pregnancies, however, failed to improve the survival rate of either SirT1+/ko pups or SirT1ko/ko pups (three or four pregnancies in 3 months for each of three SirT1ko/ko females tested), indicating that the lactation defect persisted. A SirT1 deficiency therefore affected ductal morphogenesis in virgin mice, and lobuloalveolar proliferation in parous mice.
###end p 45
###begin title 46
Deregulated negative feedback signals
###end title 46
###begin p 47
###xml 89 95 89 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 156 162 156 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 380 382 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 383 385 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 386 388 382 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 630 636 626 632 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 102 106 <span type="species:ncbi:10090">mice</span>
###xml 162 166 <span type="species:ncbi:10090">mice</span>
###xml 235 239 <span type="species:ncbi:10090">mice</span>
###xml 286 290 <span type="species:ncbi:10090">mice</span>
###xml 636 640 <span type="species:ncbi:10090">mice</span>
The characterization of lactation failure has revealed two developmental defects in SirT1ko/ko female mice. The impeded ductal morphogenesis in virgin SirT1ko/ko mice bore some resemblance to the defective ductal morphogenesis seen in mice lacking GH, estrogen, or IGF-1, as well as in mice harboring mutations in the corresponding receptors, such as the GH receptor and ERalpha [17,24-31]. These previous studies have established the notion that GH and estrogen synergistically stimulate ductal morphogenesis, which is mediated by stromal cell-produced local IGF-1 in mammary tissues. Impeded ductal morphogenesis in virgin SirT1ko/ko mice is therefore probably due to a deficit in IGF-1 signaling.
###end p 47
###begin p 48
###xml 86 92 86 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 290 292 278 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 496 498 476 478 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 621 623 597 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 729 731 701 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 732 734 704 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 735 737 707 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 745 751 717 723 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 1254 1260 1202 1208 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 1306 1312 1254 1260 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 1344 1346 1292 1294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3b</xref>
###xml 1457 1459 1397 1399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3b</xref>
###xml 1507 1509 1447 1449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1510 1512 1450 1452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1513 1515 1453 1455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
###xml 210 214 <span type="species:ncbi:10090">mice</span>
###xml 314 318 <span type="species:ncbi:10090">mice</span>
###xml 538 542 <span type="species:ncbi:10090">mice</span>
###xml 751 755 <span type="species:ncbi:10090">mice</span>
###xml 1260 1264 <span type="species:ncbi:10090">mice</span>
###xml 1312 1316 <span type="species:ncbi:10090">mice</span>
In addition to this early defect, pregnancy-induced mammary gland development in SirT1ko/ko mice appeared to be arrested at the beginning of lobuloalveolar development, which is reminiscent of the phenotype in mice lacking IkappaB kinase alpha (IKKalpha) activity for NF-kappaB activation [37]. IKKalpha-deficient mice exhibit normal ductal morphogenesis at the onset of puberty and exhibit normal ductal side branching during early pregnancy. Owing to the absence of NF-kappaB-dependent cyclin D1 expression, however, IKKalpha-deficient mice display defective alveolar epithelial cell proliferation and fail to lactate [37]. While SirT1 negatively regulates the transcription activity of FoxOs and NF-kappaB in mammalian cells [10,11,20], SirT1ko/ko mice displayed the loss-of-function phenotypes. We hypothesized that SirT1 deficiency deregulates the expression of negative feedback signals and thereby desensitizes the cells to various types of stimulation. Indeed, among the many FoxOs and NF-kappaB-regulated genes, IGFBP-1 and IkappaBalpha encode negative feedback signals for IGF-1 signaling and NF-kappaB activation, respectively. We found that the basal levels of both IGFBP-1 and IkappaBalpha were increased in adipose tissues from virgin SirT1ko/ko mice and in ductal epithelial cells from SirT1ko/ko mice on lactation day 1 (Figure 3b). Meanwhile, the expression pattern of IGFBP-1 and IkappaBalpha in wild-type mammary tissues, shown in Figure 3b, was in agreement with the findings of others [16,38,39]. Namely, the expression of IGFBP-1 was downregulated during pregnancy, whereas NF-kappaB activity was increased at a late stage of pregnancy. The loss of SirT1 therefore increased the basal level of both IGFBP-1 and IkappaBalpha in multilineages of cells, and potentially increased thresholds for activating SirT1-modulated signaling pathways.
###end p 48
###begin p 49
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2c</xref>
###xml 495 501 487 493 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 610 618 598 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 619 621 607 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 703 709 691 697 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 943 945 923 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4b</xref>
###xml 1102 1104 1082 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3b</xref>
###xml 1252 1258 1232 1238 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 709 713 <span type="species:ncbi:10090">mice</span>
###xml 1089 1093 <span type="species:ncbi:10090">mice</span>
###xml 1258 1262 <span type="species:ncbi:10090">mice</span>
SirT1 deficiency did not affect the ability of mammary epithelial progenitor cells to differentiate into functional alveolar epithelial cells despite the lactation failure (Figure 2c). SirT1 deficiency may therefore alter the homeostasis of the signals for ductal morphogenesis and/or the cellular response to the signals. Increased expression of both IGFBP-1 and IkappaBalpha in adipose tissues and mammary epithelial cells could simply reflect a global deregulation of gene expression in SirT1ko/ko cells in which the activity of both FoxOs and NF-kappaB is increased. IGFBP-1 is a potent inhibitor of IGF-1 in vivo [40], suggesting that the elevated basal level of IGFBP-1 in adipose tissues in SirT1ko/ko mice could reduce the effect of IGF-1. Moreover, deregulated IGFBP-1 expression, but not deregulated IkappaBalpha expression, was reversed in response to increased levels of estrogen in the mammary fat pads after implantation (Figure 4b). The finding is relevant to the fact that the expression of IGFBP-1 is downregulated as the level of estrogen increases in pregnant wild-type mice (Figure 3b). Increased levels of estrogen therefore stimulate the production of stromal cell-derived local IGF-1, which overcomes the IGFBP-1 barrier in SirT1ko/ko mice and, ultimately, reverses the increased levels of IGFBP-1 in mammary tissues.
###end p 49
###begin p 50
###xml 125 127 117 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4b</xref>
###xml 195 201 179 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 340 346 312 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 556 562 500 506 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 622 623 566 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 631 640 575 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
It was noted that increased levels of estrogen and local IGF-1 did not interfere with the expression of IkappaBalpha (Figure 4b). To determine whether deregulated IkappaBalpha expression in SirT1ko/ko cells can be reversed, we treated MEFs with TNFalpha and measured the kinetics of IkappaBalpha expression. Three independent lines of SirT1ko/ko MEFs were used, which displayed varying basal levels of increased IkappaBalpha expression. Following IkappaBalpha degradation induced by TNFalpha, the levels of newly synthesized IkappaBalpha in all three SirT1ko/ko MEFs were always higher than that of wild-type MEFs (Figure 6). This in vitro finding implies that SirT1 deficiency affects NF-kappaB signaling when the IkappaB kinase activation is normal.
###end p 50
###begin p 51
###xml 110 117 106 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 343 345 306 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 516 518 471 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 519 521 474 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 653 655 600 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 872 873 807 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 1069 1075 1000 1006 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 1139 1141 1070 1072 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 1370 1376 1293 1299 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 1075 1079 <span type="species:ncbi:10090">mice</span>
###xml 1383 1387 <span type="species:ncbi:10090">mice</span>
Our current system might not be suitable for studying the effects of SirT1 deficiency on NF-kappaB activation in vivo. NF-kappaB signaling exhibits distinct biological responses because the expression of IkappaBalpha depends on NF-kappaB activation while the other isoforms of IkappaB (beta and epsilon) are independent of NF-kappaB feedback [41]. For example, TNFalpha stimulation induces dampened oscillatory behavior after the first hour, whereas lipopolysacharide treatment leads to stable NF-kappaB activation [42,43]. The NF-kappaB signaling in the developing mammary gland is under the temporal control of RANK signaling and IKKalpha activation [37]. The finding of increased levels of newly synthesized IkappaBalpha within the first hour indicated that SirT1 deficiency could disrupt the temporal control of NF-kappaB signaling to all types of stimulation (Figure 6). It remains unknown, however, whether the reduced IGF-1 signaling would affect the efficacy of RANK signaling and IKKalpha activation in developing mammary glands. The fact that individual SirT1ko/ko mice manifested varying degrees of ductal morphogenesis (Figure 3a) makes it difficult to dissect the potential compound effect of SirT1 deficiency on both upstream IKKalpha activation and downstream NF-kappaB signaling. Other experimental systems, such as mammary epithelial cell-specific SirT1ko/ko female mice, may be used to address this issue.
###end p 51
###begin title 52
Discussion
###end title 52
###begin p 53
###xml 18 24 18 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 299 305 299 305 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 24 28 <span type="species:ncbi:10090">mice</span>
###xml 305 309 <span type="species:ncbi:10090">mice</span>
Our study of SirT1ko/ko mice has unveiled a regulatory mechanism by which SirT1 modulates the efficacy of estrogen-stimulated local IGF-1 signaling for ductal morphogenesis. SirT1 deficiency alters the homeostasis of gene expression and attenuates the efficacy of IGF-1 signaling. As a result, SirT1ko/ko mice manifest partial perinatal lethality and lactation failure phenotypes, implicating the role of evolutionarily conserved SirT1 in both postnatal survival and offspring survival of mammals.
###end p 53
###begin title 54
###xml 52 59 52 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
SirT1 balances the homeostasis of IGF-1 and IGFBP-1 in vivo
###end title 54
###begin p 55
###xml 213 215 213 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7a</xref>
###xml 538 540 538 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 541 543 541 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 703 704 703 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 705 706 705 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 707 709 707 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1185 1187 1185 1187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 1211 1217 1211 1217 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 1346 1348 1346 1348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1c</xref>
###xml 1359 1360 1359 1360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1363 1365 1363 1365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1366 1368 1366 1368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1812 1818 1812 1818 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 1914 1916 1914 1916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1c</xref>
###xml 2076 2078 2076 2078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 409 413 <span type="species:ncbi:10090">Mice</span>
###xml 998 1002 <span type="species:ncbi:10090">Mice</span>
###xml 1179 1183 <span type="species:ncbi:10090">mice</span>
###xml 1217 1221 <span type="species:ncbi:10090">mice</span>
###xml 1268 1272 <span type="species:ncbi:10090">mice</span>
###xml 1484 1488 <span type="species:ncbi:10090">mice</span>
###xml 1818 1822 <span type="species:ncbi:10090">mice</span>
###xml 1971 1975 <span type="species:ncbi:10090">mice</span>
###xml 2017 2021 <span type="species:ncbi:10090">mice</span>
SirT1 is an integral part of the IIS system that checks and balances the efficacy of insulin and IGF-1 signals. The IGF-1 signaling of the IIS system is required for survival after birth. As illustrated in Figure 7a, the function of SirT1 parallels the linear IGF-1/IGF-1 receptor/phosphoinositide-3'-OH kinase/Akt signaling pathway, both of which can negatively regulate the transcription activity of FoxOs. Mice harboring targeted mutations in either IGF-1 or the IGF-1 receptor gene exhibit perinatal lethality and growth retardation [44,45]. In the IGF-1 receptor-expressing cells, the binding of insulin and/or IGF-1 activates the phosphoinositide-3'-OH kinase and Akt kinase cascade for survival [8,9,13]. The phosphoinositide-3'-OH kinase/Akt signaling pathway is also highly conserved from worms to mammals, and functions to modulate energy metabolism and lifespan in lower organisms. The mammalian Akt kinase family has three members, Akt1-Akt3, which provide specificity and versatility. Mice lacking both the Akt1 and Akt2 genes display perinatal lethal and growth retardation phenotypes that are strikingly similar to that of either IGF-1 or IGF-1 receptor-deficient mice [46]. In this regard, SirT1ko/ko mice, as well as other strains of SirT1-deficienct mice, also exhibit perinatal lethal and growth retardation phenotypes (Figure 1c and Table 1) [22,23]. The consistent observation of perinatal lethal and growth retardation phenotypes from our study and studies with mice lacking IGF-1, the IGF-1 receptor, or Akt1/Akt2 suggests that upregulated FoxO activity unleashes the expression of downstream effector genes that lead to the birth-related stress. This birth-related stress may be related to the switch from a maternal level of IGF-1 to a neonatal level of IGF-1 because the surviving SirT1ko/ko mice can live into adulthood and can reproduce despite the growth retardation phenotype (Figure 1c). In this context, at least one of the FoxO-deficient mice strains, FoxO3 (Foxo3a/FKHRL1)-deficient mice, grow normally and develop functional mammary glands [47].
###end p 55
###begin p 56
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 207 209 207 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 210 212 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 327 329 327 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 330 332 330 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 478 480 478 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7a</xref>
###xml 552 559 552 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
IGFBP-1 is one of six IGF-1 binding proteins, but is the only one that can be negatively regulated by insulin [48]. IGF-1 binding proteins inhibit the action of local IGF-1 in a spatial and temporal manner [40,49]. In mammalian cells, FoxO3 can directly bind to the promoter of the IGFBP-1 gene and activate the transcription [50-52]. SirT1 acts to negatively regulate the activity of nuclear FoxO3 and to decrease the expression of IGFBP-1 when the IGF-1 signal is low (Figure 7a). Increased levels of IGFBP-1 can diminish the action of IGF-1 signals in vivo. In that way, SirT1 balances the homeostasis of IGF-1 and IGFBP-1 for varying levels of IGF-1 signals.
###end p 56
###begin p 57
###xml 160 162 160 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 353 355 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 376 382 372 378 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 500 501 496 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 591 597 587 593 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 1087 1089 1079 1081 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 1090 1092 1082 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 126 130 <span type="species:ncbi:10090">mice</span>
###xml 143 158 <span type="species:ncbi:10090">transgenic mice</span>
###xml 225 229 <span type="species:ncbi:10090">mice</span>
###xml 290 294 <span type="species:ncbi:10090">mice</span>
###xml 382 386 <span type="species:ncbi:10090">mice</span>
###xml 604 608 <span type="species:ncbi:10090">mice</span>
###xml 976 980 <span type="species:ncbi:10090">mice</span>
###xml 1080 1085 <span type="species:ncbi:9606">women</span>
###xml 1395 1399 <span type="species:ncbi:10090">mice</span>
The homeostasis of IGF-1 and IGFBP-1 clearly affects fertility, as shown by the infertility phenotype in both IGF-1-deficient mice and IGFBP-1 transgenic mice [28,40,49]. The serum level of estrogen in IGF-1-deficient female mice appears significantly reduced, whereas in ERalpha-deficient mice, which are also infertile, there is a threefold increase [53]. In contrast, SirT1ko/ko mice can be fertile despite the fact that the fertility was reduced as compared with that of wild-type females (Table 1). Although our preliminary assessment indicated that the serum level of estrogen in SirT1ko/ko female mice was not overtly altered, it remains possible that a subtle irregularity or an individual variation of the estrogen level or ERalpha expression might be attributed to the reduced fertility. An alternative explanation for reduced fertility is that SirT1 deficiency deregulates the activity of FoxO3 and manifests an opposite effect of FoxO3 deficiency. FoxO3-deficient mice exhibit early depletion of ovarian follicles, which is reminiscent of premature ovarian failure in women [47,54]. Premature ovarian failure manifests as early cessation of ovarian function and as premature menopause caused by genetic mutations, chemo/radiation therapy, or other unknown factors. It is possible that SirT1 deficiency counterbalances normal release of ovarian follicles and reduces the fertility in mice.
###end p 57
###begin title 58
SirT1 modulates the efficacy of the IGF-1 signal for ductal morphogenesis
###end title 58
###begin p 59
###xml 36 42 36 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7b</xref>
###xml 403 409 403 409 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 466 468 466 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2a</xref>
###xml 473 475 473 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 575 581 575 581 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 595 597 595 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 602 604 602 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4a</xref>
###xml 874 880 874 880 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 893 895 893 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 1073 1079 1073 1079 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 1120 1122 1120 1122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4b</xref>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
###xml 409 413 <span type="species:ncbi:10090">mice</span>
###xml 581 585 <span type="species:ncbi:10090">mice</span>
###xml 755 759 <span type="species:ncbi:10090">mice</span>
###xml 812 817 <span type="species:ncbi:10090">mouse</span>
###xml 880 884 <span type="species:ncbi:10090">mice</span>
###xml 1079 1083 <span type="species:ncbi:10090">mice</span>
We hypothesize that, in virgin SirT1ko/ko mice, increased levels of IGFBP-1 in adipose tissues effectively diminish IGF-1 signals, including the estrogen-IGF-1 signaling, and halt the differentiation of mammary epithelial progenitor cells (Figure 7b). Several results of this study provided support for this hypothesis. First, the expression of IGFBP-1 is increased in mammary fat pads from virgin SirT1ko/ko mice, in which there is no evidence of any duct (Figures 2a and 3a). Second, both pregnancy and estrogen implantation can rescue impeded ductal morphogenesis in SirT1ko/ko mice (Figures 3a and 4a), demonstrating that increased levels of estrogen can enhance the production of local IGF-1. Moreover, the varying degrees of rescue among individual mice, as well as individual mammary fat pads of the same mouse, also indicated that local IGF-1 must be halted in SirT1ko/ko mice (Figure 3a, and data not shown). Finally, increased levels of estrogen specifically activate the IGF-1 signaling in mammary tissues, as shown by the reversal of IGFBP-1 expression in SirT1ko/ko mice after estrogen implantation (Figure 4b). These results indicate that a gradient of IGF-1 signals, including both circulating and local IGF-1, may regulate mammary gland development at embryonic, postnatal, and reproductive stages, and that increased expression of IGFBP-1 decreases the efficacy of IGF-1 signals.
###end p 59
###begin p 60
###xml 409 411 409 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 412 414 412 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 415 417 415 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 774 776 774 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7b</xref>
###xml 966 968 962 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 969 971 965 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 972 974 968 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1333 1335 1325 1327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7b</xref>
###xml 1663 1665 1655 1657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7b</xref>
###xml 1720 1726 1712 1718 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 880 884 <span type="species:ncbi:10090">mice</span>
###xml 1726 1730 <span type="species:ncbi:10090">mice</span>
Mammary development may undergo estrogen/IGF-1-independent phases and estrogen/IGF-1-dependent phases, which encompasses a late stage of embryonic development to the onset of puberty and involves maternal IGF-1, circulating IGF-1, and estrogen-stimulated local IGF-1. By embryonic day 16.5, mammary mesenchymes are connected to primitive fat pads and begin to proliferate, which results in rudimentary ducts [17,25,55,56]. We propose that this process marks the transition from estrogen/IGF-1-independent mammary stem cells to IGF-1-dependent epithelial progenitor cells, and that maternal IGF-1 is sufficient to stimulate the differentiation of epithelial progenitor cells to estrogen-independent ductal epithelial cells but not estrogen-dependent epithelial cells (Figure 7b). This explains why the development of rudimentary ducts is normal in either IGF-1 or ERalpha knockout mice and that TEBs form and regress immediately before and after birth, respectively [17,26,27]. During the prepubertal period, the rudimentary ducts grow isometrically under the influence of circulating IGF-1. Like maternal IGF-1, circulating IGF-1 is not sufficient to induce the differentiation of estrogen-independent ductal epithelial cells into estrogen-dependent epithelial cells, which will express ERalpha and become estrogen dependent (Figure 7b). At the onset of puberty, ovarian estrogen, in synergy with pituitary GH, causes a surge in the production of stromal cell-derived local IGF-1 and stimulates the differentiation of estrogen-independent ductal epithelial cells to estrogen-dependent epithelial cells, which begins postnatal development of mammary gland (Figure 7b). Impeded ductal morphogenesis results in virgin SirT1ko/ko mice because local IGF-1 is apparently not sufficient to overcome increased IGFBP-1 in mammary adipose tissues. SirT1 therefore positively regulates the efficacy of the estrogen-IGF-1 signaling for ductal epithelial cell proliferation and differentiation.
###end p 60
###begin title 61
The potential effect of modulating SirT1 activity
###end title 61
###begin p 62
###xml 718 720 718 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 721 723 721 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 999 1001 999 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 302 307 <span type="species:ncbi:9606">woman</span>
###xml 364 369 <span type="species:ncbi:9606">woman</span>
###xml 971 976 <span type="species:ncbi:9606">women</span>
Breast cancer results from the accumulation of inherited and/or somatic mutations. Lifetime exposure to estrogen is a major risk factor for breast cancer, and a number of lifestyle factors, such as diet, body fat, alcohol consumption, exercise, parity, and hormone replacement therapy, may influence a woman's exposure to estrogen. The compound personal risk to a woman is difficult to assess because the molecular link between these factors and the effect of estrogen is poorly understood. The result of this study demonstrated that SirT1 positively modulates the efficacy of the estrogen-IGF-1 signal. This suggests that if SirT1 serves as a lifetime sensor to dietary restriction and acute withdrawal of nutrients [14,57], its activity could ultimately influence the risk of breast cancer. Interestingly, an epidemiological study of Dutch famine in 1945 indicated that an exposure to famine at prepubertal age increased the risk of breast cancer, most clearly seen in women who never gave birth [58]. Moreover, the serum levels of estrogen and IGF-1 were increased among those exposed to the famine, which suggests that an epigenetic adaptation phenomenon may take place. Assessing the potential correlation between the enzymatic activity of SirT1 and the risk of breast cancer is therefore of great interest in order to identify feasible targets for chemoprevention against breast cancer.
###end p 62
###begin p 63
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 123 125 123 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 319 325 319 325 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 178 184 <span type="species:ncbi:9606">humans</span>
###xml 325 329 <span type="species:ncbi:10090">mice</span>
Several dietary polyphenols as well as small molecules have been identified as either agonists or antagonists of SirT1 [59,60]. The pharmacological effects of these compounds in humans remain elusive given that SirT1 targets multiple transcription factors and exerts pleiotropic effects. Nonetheless, our study of SirT1ko/ko mice demonstrated the potential utility of SirT1 antagonists. Specifically, reducing SirT1 activity alters the homeostasis of cellular responses, including deregulation of the expression of IGFBP-1 and IkappaBalpha, which can attenuate the stimulation from the estrogen-IGF-1 signaling and potentially desensitize mammary epithelial cells to NF-kappaB activation. SirT1 is therefore a candidate target for chemoprevention against breast cancer.
###end p 63
###begin title 64
Conclusion
###end title 64
###begin p 65
The study of mammary gland development is an excellent model system for unraveling how SirT1 modulates the efficacy of the estrogen-IGF-1 signaling and regulates the timing of ductal morphogenesis. These new mechanistic insights may also aid in understanding the role of SirT1 in breast cancer as well as in other organs in which local IGF-1 plays an important role.
###end p 65
###begin title 66
Abbreviations
###end title 66
###begin p 67
###xml 54 57 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 444 450 <span type="species:ncbi:10090">murine</span>
Atm = ataxia telangiectasia; BrdU = bromodeoxyurdine; CMV = cytomegalovirus; ERalpha = estrogen receptor alpha; FoxO = forkhead box 'other' protein; GH = growth hormone; IGF-1 = insulin-like growth factor-1; IGFBP-1 = insulin-like growth factor-1 binding protein-1; H & E = hemotoxylin and eosin; IIS = insulin/insulin-like growth factor-1 signaling; IkappaBalpha = inhibitors of NF-kappaB alpha subunit; IKKalpha = IkappaB kinase alpha; MEF = murine embryonic fibroblast; NF = nuclear factor; PCR = polymerase chain reaction; RANK = receptor activator of NF-kappaB; Sir = silencing information regulator; TEB = terminal end bud; TNF = tumor necrosis factor.
###end p 67
###begin title 68
Competing interests
###end title 68
###begin p 69
The authors declare that they have no competing interests.
###end p 69
###begin title 70
Authors' contributions
###end title 70
###begin p 71
###xml 52 56 <span type="species:ncbi:10090">mice</span>
###xml 240 244 <span type="species:ncbi:10090">mice</span>
HL characterized the phenotypes of the SirT1 mutant mice, participated in the design of the study, and helped to draft the manuscript. GKR and NL helped to characterize the phenotypes. CW generated the SirT1 mutant embryonic stem cells and mice. BPR helped analyze the histology data. YG conceived of the study, participated in its design and coordination, and drafted the manuscript. All authors read and approved the final manuscript.
###end p 71
###begin title 72
Supplementary Material
###end title 72
###begin title 73
Additional file 1
###end title 73
###begin p 74
###xml 75 81 75 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 183 189 183 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink">co/co </sup>
###xml 203 209 203 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 81 85 <span type="species:ncbi:10090">mice</span>
###xml 189 193 <span type="species:ncbi:10090">mice</span>
###xml 209 213 <span type="species:ncbi:10090">mice</span>
A pdf file containing the materials and methods for the generation of SirT1ko/ko mice. This supporting file documented the details of materials and methods used to generate both SirT1co/co mice and SirT1ko/ko mice.
###end p 74
###begin p 75
Click here for file
###end p 75
###begin title 76
Acknowledgements
###end title 76
###begin p 77
The study is supported by grants from the American Cancer Society (RSG-04-019-01-CNE) and the Nathan Shock Center of Excellence in the Biology of Aging at the University of Washington (to YG). The authors thank Jennifer Blasi, Thomas Gernon, Janet Leath, Jennifer Lee, Bryce Sopher, Loraine Warner, and Heather-Marie Wilson for their contributions in the early phases of the study, and Dr Fred Alt, Dr Mary Helen Barcellos-Hoff, Dr Mark Groudine, Dr Warren Ladiges, Dr George Martin, Dr Peter Rabinovitch, and Dr Jeffrey Schwartz for their support and advice.
###end p 77
###begin article-title 78
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
###end article-title 78
###begin article-title 79
The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases
###end article-title 79
###begin article-title 80
###xml 89 102 89 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. cerevisiae</italic>
###xml 89 102 <span type="species:ncbi:4932">S. cerevisiae</span>
Modifiers of position effect are shared between telomeric and silent mating-type loci in S. cerevisiae
###end article-title 80
###begin article-title 81
###xml 49 54 <span type="species:ncbi:4932">yeast</span>
Molecular model for telomeric heterochromatin in yeast
###end article-title 81
###begin article-title 82
###xml 78 102 78 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 78 102 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae
###end article-title 82
###begin article-title 83
###xml 53 75 53 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Caenorhabditis elegans</italic>
###xml 53 75 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans
###end article-title 83
###begin article-title 84
Sir2 blocks extreme life-span extension
###end article-title 84
###begin article-title 85
The plasticity of aging: insights from long-lived mutants
###end article-title 85
###begin article-title 86
The role of insulin and IGF-1 signaling in longevity
###end article-title 86
###begin article-title 87
Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase
###end article-title 87
###begin article-title 88
Mammalian SIRT1 represses forkhead transcription factors
###end article-title 88
###begin article-title 89
Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity
###end article-title 89
###begin article-title 90
Cellular survival: a play in three Akts
###end article-title 90
###begin article-title 91
Calorie restriction - the SIR2 connection
###end article-title 91
###begin article-title 92
Steroid receptor phylogeny and vertebrate origins
###end article-title 92
###begin article-title 93
###xml 92 98 <span type="species:ncbi:10090">murine</span>
The insulin-like growth factors (IGFs) and IGF binding proteins in postnatal development of murine mammary glands
###end article-title 93
###begin article-title 94
Establishing a framework for the functional mammary gland: from endocrinology to morphology
###end article-title 94
###begin article-title 95
Negative control of p53 by Sir2alpha promotes cell survival under stress
###end article-title 95
###begin article-title 96
hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase
###end article-title 96
###begin article-title 97
Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase
###end article-title 97
###begin article-title 98
Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1
###end article-title 98
###begin article-title 99
The mammalian SIR2alpha protein has a role in embryogenesis and gametogenesis
###end article-title 99
###begin article-title 100
###xml 81 85 <span type="species:ncbi:10090">mice</span>
Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice
###end article-title 100
###begin article-title 101
Postnatal mammary gland morphogenesis
###end article-title 101
###begin article-title 102
###xml 69 76 69 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 39 44 <span type="species:ncbi:10090">mouse</span>
###xml 49 54 <span type="species:ncbi:9606">human</span>
Epithelial-stromal interactions in the mouse and human mammary gland in vivo
###end article-title 102
###begin article-title 103
###xml 55 59 <span type="species:ncbi:10090">mice</span>
###xml 130 134 <span type="species:ncbi:10090">mice</span>
Mammary gland branching morphogenesis is diminished in mice with a deficiency of insulin-like growth factor-I (IGF-I), but not in mice with a liver-specific deletion of IGF-I
###end article-title 103
###begin article-title 104
###xml 35 39 <span type="species:ncbi:10090">mice</span>
Mammary gland development in adult mice requires epithelial and stromal estrogen receptor alpha
###end article-title 104
###begin article-title 105
###xml 41 46 <span type="species:ncbi:10090">mouse</span>
Effects of an Igf1 gene null mutation on mouse reproduction
###end article-title 105
###begin article-title 106
Early mammary development: growth hormone and IGF-1
###end article-title 106
###begin article-title 107
Evidence that the mammary fat pad mediates the action of growth hormone in mammary gland development
###end article-title 107
###begin article-title 108
Insulin-like growth factor I is essential for terminal end bud formation and ductal morphogenesis during mammary development
###end article-title 108
###begin article-title 109
###xml 65 89 65 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 65 89 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Silencing factors participate in DNA repair and recombination in Saccharomyces cerevisiae
###end article-title 109
###begin article-title 110
MEC1-dependent redistribution of the Sir3 silencing protein from telomeres to DNA double-strand breaks
###end article-title 110
###begin article-title 111
Genomic instability and aging-like phenotype in the absence of mammalian SIRT6
###end article-title 111
###begin article-title 112
###xml 62 66 <span type="species:ncbi:10090">mice</span>
Growth retardation and leaky SCID phenotype of Ku70-deficient mice
###end article-title 112
###begin article-title 113
###xml 69 73 <span type="species:ncbi:10090">mice</span>
Abnormal development of Purkinje cells and lymphocytes in Atm mutant mice
###end article-title 113
###begin article-title 114
###xml 71 73 67 69 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development
###end article-title 114
###begin article-title 115
###xml 32 38 <span type="species:ncbi:10090">murine</span>
NF-kappaB inhibits apoptosis in murine mammary epithelia
###end article-title 115
###begin article-title 116
Activation of NF-kappaB p50/p65 is regulated in the developing mammary gland and inhibits STAT5-mediated beta-casein gene expression
###end article-title 116
###begin article-title 117
###xml 66 81 <span type="species:ncbi:10090">transgenic mice</span>
Overexpression of insulin-like growth factor binding protein-1 in transgenic mice
###end article-title 117
###begin article-title 118
The IkapppaB-NF-kappaB signalling module:temporal control and selective gene activation
###end article-title 118
###begin article-title 119
Achieving stability of lipopolysaccharide-induced NF-kappaB activation
###end article-title 119
###begin article-title 120
Stimulus specificity of gene expression programs determined by temporal control of IKK activity
###end article-title 120
###begin article-title 121
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r)
###end article-title 121
###begin article-title 122
###xml 49 53 <span type="species:ncbi:10090">mice</span>
IGF-I is required for normal embryonic growth in mice
###end article-title 122
###begin article-title 123
###xml 116 120 <span type="species:ncbi:10090">mice</span>
Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2
###end article-title 123
###begin article-title 124
###xml 46 50 <span type="species:ncbi:10090">mice</span>
Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a
###end article-title 124
###begin article-title 125
###xml 61 66 <span type="species:ncbi:9606">human</span>
Production of insulin-like growth factor-binding proteins by human central nervous system tumors
###end article-title 125
###begin article-title 126
###xml 11 16 <span type="species:ncbi:10090">mouse</span>
Transgenic mouse models for studying the functions of insulin-like growth factor-binding proteins
###end article-title 126
###begin article-title 127
Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence
###end article-title 127
###begin article-title 128
Negative regulation of the forkhead transcription factor FKHR by Akt
###end article-title 128
###begin article-title 129
FKHR binds the insulin response element in the insulin-like growth factor binding protein-1 promoter
###end article-title 129
###begin article-title 130
###xml 51 56 <span type="species:ncbi:10090">mouse</span>
Progesterone action and responses in the alphaERKO mouse
###end article-title 130
###begin article-title 131
Premature ovarian failure
###end article-title 131
###begin article-title 132
Key stages of mammary gland development: molecular mechanisms involved in the formation of the embryonic mammary gland
###end article-title 132
###begin article-title 133
Paracrine signaling through the epithelial estrogen receptor alpha is required for proliferation and morphogenesis in the mammary gland
###end article-title 133
###begin article-title 134
Nutrient availability regulates SIRT1 through a forkhead-dependent pathway
###end article-title 134
###begin article-title 135
Breast cancer and the brain: a neurodevelopmental hypothesis to explain the opposing effects of caloric deprivation during the Dutch famine of 1944-1945 on breast cancer and its risk factors
###end article-title 135
###begin article-title 136
SIRT1 stimulation by polyphenols is affected by their stability and metabolism
###end article-title 136
###begin article-title 137
###xml 52 57 <span type="species:ncbi:9606">human</span>
Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes
###end article-title 137
###begin title 138
Figures and Tables
###end title 138
###begin p 139
###xml 40 46 40 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink">co/co </sup>
###xml 55 61 55 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 0 65 0 65 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Generation and characterization of SirT1<sup>co/co </sup>and SirT1<sup>ko/ko </sup>mice</bold>
###xml 67 71 67 71 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 106 107 106 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 144 146 144 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink">co</sup>
###xml 175 177 175 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko</sup>
###xml 183 187 183 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BamH</italic>
###xml 190 194 190 194 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 390 394 390 394 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c) </bold>
###xml 431 437 431 437 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 527 531 527 531 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(d) </bold>
###xml 613 618 613 618 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/ko </sup>
###xml 635 641 635 641 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 655 659 655 659 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(e) </bold>
###xml 703 708 703 708 <sup xmlns:xlink="http://www.w3.org/1999/xlink">co/co</sup>
###xml 715 720 715 720 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko</sup>
###xml 730 734 730 734 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 781 785 781 785 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(f) </bold>
###xml 828 833 828 833 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko</sup>
###xml 839 842 839 842 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 851 855 851 855 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 61 65 <span type="species:ncbi:10090">mice</span>
###xml 71 76 <span type="species:ncbi:10090">Mouse</span>
###xml 328 334 <span type="species:ncbi:10090">murine</span>
###xml 437 441 <span type="species:ncbi:10090">mice</span>
###xml 467 471 <span type="species:ncbi:10090">mice</span>
###xml 487 491 <span type="species:ncbi:10090">mice</span>
###xml 649 653 <span type="species:ncbi:10090">mice</span>
Generation and characterization of SirT1co/co and SirT1ko/ko mice. (a) Mouse SirT1 wild-type allele (SirT1+), conditional targeted allele (SirT1co), and knockout allele (SirT1ko). B, BamHI. (b) Western blot analysis of SirT1 expression in wild-type (+/+), conditional targeted (co/co), heterozygote (+/ko), and knockout (ko/ko) murine embryonic fibroblasts (MEFs) and mammary tissues (MG). (c) Growth retardation in surviving SirT1ko/ko mice (open bar) using sibling mice or age-matched mice of control genotypes (filled bar). (d) The serum levels of insulin-like growth factor-1 (IGF-1) in wild-type (+/+), SirT1+/ko (+/ko), and SirT1ko/ko (ko/ko) mice. (e) The survival curves of wild-type (WT), SirT1co/co, SirT1ko/ko, and Ku70-/- embryonic stem cells after ionizing radiation. (f) The survival curve of wild-type (WT), SirT1ko/ko, Ku70-/-, and Atm-/- embryonic stem cells after treatment with hydrogen peroxide.
###end p 139
###begin p 140
###xml 26 32 26 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 0 36 0 36 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Lactation failure in SirT1<sup>ko/ko </sup>mice</bold>
###xml 38 42 38 42 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 123 129 123 129 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 161 165 161 165 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 250 256 250 256 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 351 355 350 354 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c) </bold>
###xml 455 461 454 460 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 32 36 <span type="species:ncbi:10090">mice</span>
###xml 129 133 <span type="species:ncbi:10090">mice</span>
###xml 263 267 <span type="species:ncbi:10090">mice</span>
###xml 461 465 <span type="species:ncbi:10090">mice</span>
###xml 495 500 <span type="species:ncbi:10090">mouse</span>
Lactation failure in SirT1ko/ko mice. (a) Whole mount analysis of the mammary tissues from virgin wild-type (+/+) and SirT1ko/ko mice (ko/ko). Scale bar = 2 mm. (b) Histological analysis of the mammary tissues harvested from wild-type (+/+) and SirT1ko/ko female mice on either day 13 of pregnancy (P13) or lactation day 1 (L1). Scale bars = 100 mum. (c) Immunofluorescence staining of milk production in the mammary tissues from wild-type (+/+) and SirT1ko/ko mice on L1. Red and smear stains, mouse milk proteins; blue dots, nuclear staining of adipocytes, epithelial cells, and other cells in mammary tissues. Scale bars = 100 mum.
###end p 140
###begin p 141
###xml 0 38 0 38 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Pregnancy-induced ductal morphogenesis</bold>
###xml 40 44 40 44 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 354 360 354 360 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 541 547 541 547 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 585 589 584 588 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 786 792 777 783 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 124 128 <span type="species:ncbi:10090">mice</span>
###xml 208 212 <span type="species:ncbi:10090">mice</span>
###xml 368 372 <span type="species:ncbi:10090">mice</span>
###xml 547 551 <span type="species:ncbi:10090">mice</span>
###xml 720 724 <span type="species:ncbi:10090">mice</span>
###xml 733 737 <span type="species:ncbi:10090">mice</span>
###xml 753 757 <span type="species:ncbi:10090">mice</span>
Pregnancy-induced ductal morphogenesis. (a) Whole mount analysis of mammary gland development. Upper panel: wild-type (+/+) mice show terminal end buds (TEBs) at the onset of puberty, elongated ducts (virgin mice), site branching during pregnancy (P13), and lobuloalveolar structures for milk production on lactation day 1 (L1). Lower panel: virgin SirT1ko/ko (ko/ko) mice show impeded ductal morphogenesis. Pregnancy-induced ductal morphogenesis manifests transitional TEBs, ductal elongation, and side branching with variety in three SirT1ko/ko mice on L1. All scale bars = 200 mum. (b) Western blot analysis of both insulin-like growth factor-1 binding protein-1 (IGFBP-1) and IkappaBalpha in mammary tissues of male mice, virgin mice, and L1 female mice of wild type (+/+) and SirT1ko/ko (ko/ko). Actin is used as a loading control. Lower panel scores the estimated density of indicated lineages of cells in the protein extracts, which are based on the morphological analyses in (a).
###end p 141
###begin p 142
###xml 0 69 0 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Estrogen implantation stimulates ductal elongation and site branching</bold>
###xml 71 75 71 75 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 160 166 160 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 253 257 252 256 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 468 474 459 465 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 166 170 <span type="species:ncbi:10090">mice</span>
###xml 474 478 <span type="species:ncbi:10090">mice</span>
Estrogen implantation stimulates ductal elongation and site branching. (a) Whole mount analysis of the mammary tissues from the virgin wild-type (+/+) and SirT1ko/ko mice implanted with estrogen pellets (+E2) on day 14 and day 21. Scale bars = 200 mum. (b) Western blot analysis of the expression of insulin-like growth factor-1 binding protein-1 (IGFBP-1) and IkappaBalpha, with actin as a loading control, in mammary tissues from the virgin wild-type (+/+) and SirT1ko/ko mice implanted with estrogen pellets on day 21.
###end p 142
###begin p 143
###xml 60 66 60 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 0 89 0 89 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Mammary epithelial cell proliferation and apoptosis in SirT1<sup>ko/ko </sup>mice on lactation day 1</bold>
###xml 91 95 91 95 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 175 181 175 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 385 391 384 390 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 673 677 670 674 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 773 779 770 776 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 858 862 855 859 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c) </bold>
###xml 66 70 <span type="species:ncbi:10090">mice</span>
###xml 209 213 <span type="species:ncbi:10090">mice</span>
###xml 391 395 <span type="species:ncbi:10090">mice</span>
###xml 454 458 <span type="species:ncbi:10090">mice</span>
###xml 779 783 <span type="species:ncbi:10090">mice</span>
###xml 815 819 <span type="species:ncbi:10090">mice</span>
Mammary epithelial cell proliferation and apoptosis in SirT1ko/ko mice on lactation day 1. (a) Upper panel: bromodeoxyurdine (BrdU) staining of the mammary sections from SirT1ko/ko (ko/ko) and wild-type (+/+) mice on day 13 of pregnancy (P13) and lactation day 1 (L1). From left to right, three terminal end buds (TEBs) at a scale of 100 mum, a single TEB, ducts, and alveolus of SirT1ko/ko mice at a scale of 20 mum, and ducts and alveolus of wild-type mice on P13 and L1 at a scale of 20 mum. Lower panel: TUNEL (Terminal deoxynucleotidyl transferase mediated dUTP Nick End Labeling) assay for apoptotic cells using sections neighbored to the sections for BrdU staining. (b) The quantitative analysis of BrdU-positive epithelial cells in TEBs, ducts, and alveoli of SirT1ko/ko mice on L1 (open bar) and wild-type mice on P13 (grey bar) and L1 (solid bar). (c) The quantitative analysis of TUNEL-positive cells in neighboring sections.
###end p 143
###begin p 144
###xml 0 80 0 72 <bold xmlns:xlink="http://www.w3.org/1999/xlink">SirT1 deficiency derails NF-&#954;B signaling in response to TNF&#945; stimulation</bold>
###xml 82 86 74 78 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 143 149 127 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 299 303 279 283 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 383 389 355 361 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 177 183 <span type="species:ncbi:10090">murine</span>
SirT1 deficiency derails NF-kappaB signaling in response to TNFalpha stimulation. (a) Western blot analysis of IkappaBalpha expression in SirT1ko/ko (ko/ko) and wild-type (+/+) murine embryonic fibroblasts (MEFs) within the first hour after TNFalpha stimulation. Actin is used as a loading control. (b) The relative levels of newly synthesized IkappaBalpha in three independent SirT1ko/ko MEF lines (red circles, blue and green triangles) and wild-type MEFs after TNFalpha stimulation. For each line of MEFs, the unit of IkappaBalpha protein at each time point is relative to the unit 0 minutes after normalization with actin.
###end p 144
###begin p 145
###xml 0 97 0 97 <bold xmlns:xlink="http://www.w3.org/1999/xlink">SirT1 modulates estrogen&#8211;insulin-like growth factor-1 signaling for ductal morphogenesis: a model</bold>
###xml 99 103 99 103 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 471 475 471 475 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 1147 1153 1147 1153 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 1259 1265 1259 1265 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 1153 1157 <span type="species:ncbi:10090">mice</span>
###xml 1265 1269 <span type="species:ncbi:10090">mice</span>
SirT1 modulates estrogen-insulin-like growth factor-1 signaling for ductal morphogenesis: a model. (a) The insulin/insulin-like growth factor-1 (IGF-1) signaling system: both SirT1 and Akt kinases can negatively regulate the transcription activity of forkhead box 'other' protein (FoxO) proteins. SirT1 deficiency deregulates the expression of insulin-like growth factor-1 binding protein-1 (IGFBP-1), which may exert autocrine and/or paracrine effects to inhibit IGF-1. (b) Mammary epithelial precursor cells (EPC) express IGF-1 receptor (IGF-1R) and can differentiate into estrogen receptor (ER)-negative ductal epithelial cells (DEC-I) in response to maternal, circulating, or estrogen-stimulated, stromal cell (S)-derived local IGF-1. At the onset of puberty, ovarian estrogen, in synergy with growth hormone (GH), enhances the production of local IGF-1 and stimulates the differentiation of DEC-I to ER-positive ductal epithelial cells (DEC-II). SirT1 deficiency deregulates the expression of IGFBP-1 in adipose tissues (a), however, which attenuates the efficacy of the IGF-1 signaling and causes impeded ductal morphogenesis in virgin SirT1ko/ko mice. Either pregnancy or exogenous estrogen can overcome the impeded ductal morphogenesis in virgin SirT1ko/ko mice and can stimulate the differentiation of EPC.
###end p 145
###begin p 146
###xml 61 67 61 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ko/ko </sup>
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Perinatal lethality, fertility, and lactation defect in SirT1ko/ko mice
###end p 146
###begin p 147
###xml 27 32 27 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/ko </sup>
###xml 51 56 51 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/ko </sup>
###xml 201 202 201 202 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 37 41 <span type="species:ncbi:10090">mice</span>
###xml 63 67 <span type="species:ncbi:10090">mice</span>
More than 10 pairs of SirT1+/ko male mice and SirT1+/ko female mice were used for breeding. Data in parentheses indicate the number of pups of this genotype found dead within 3 days after their birth. aTotal number of surviving pups at weaning (postnatal day 21).
###end p 147

